--- title: "关于伊维菌素与癌症的突破性新研究" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/285481613.md" description: "一项由 The Wellness Company 主导的研究显示，伊维菌素和美班唑的非标签使用在癌症治疗中具有 84% 的临床获益比。分析了 197 名患者，其中 48% 报告癌症缓解或没有疾病证据，36% 则经历了病情稳定。该研究强调了对这些药物作为潜在癌症治疗手段进行进一步科学研究的必要性，尤其是在对医疗系统日益增长的不信任背景下。The Wellness Company 提供这些药物的 90 天供应，强调其安全性和有效性" datetime: "2026-05-07T04:02:20.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285481613.md) - [en](https://longbridge.com/en/news/285481613.md) - [zh-HK](https://longbridge.com/zh-HK/news/285481613.md) --- # 关于伊维菌素与癌症的突破性新研究 Before the COVID-19 pandemic, the vast majority of Americans – regardless of their ideological leanings – simply trusted the medical establishment. That trust was devastated by the experience of the pandemic. According to polling, in April 2020 – at the outbreak of the pandemic – 71.5% of respondents reported having “a lot of trust” in physicians and hospitals. By January 2024, that number had plummeted to 40.1%. Unfortunately, trust in our healthcare system and its institutions has been undermined by a belief that decisions are being made – not based on what is in the best interest of Americans healthcare – but what is in the best interest of corporate bottom lines. To restore faith in our system, we need research and treatment that is focused on the patient’s health – not just profit. That’s where The Wellness Company comes in. Dr. Peter McCullough, and a number of his colleagues at The Wellness Company, have recently authored a first of its kind study of the application of Ivermectin+Mebendazole in the treatment of cancer. 84% of Cancer Patients Reported a Clinical Benefit In this human observational analysis, off-label use of Ivermectin+Mebendazole showed a remarkable 84% Clinical Benefit Ratio in the treatment of cancer . These results indicate that the inexpensive and safe off-label applications of these medications could be an important breakthrough in the treatment of cancer. The report analyzed 197 cancer patients who were prescribed ivermectin and mebendazole off label. Participants received compounded oral capsules containing 25 mg of ivermectin and 250 mg of mebendazole. After 6-months, participants reported an 84% Clinical Benefit Ratio. With 48% of participants reporting regression or no evidence of cancer, while 36% reported disease stability. Only 15.6% of participants reported disease progression. Cancer remains one of the leading causes of death globally, with conventional treatments such as chemotherapy, radiation therapy, and targeted agents frequently limited by significant toxicity, high cost, development of resistance, and variable long-term efficacy. The experts at The Wellness Company undertook this study because ivermectin and mebendazole have demonstrated highly promising anti-cancer activity in preclinical models. But despite compelling preclinical data and documented safe use in cancer patients, robust clinical evidence evaluating the ivermectin–mebendazole combination in oncology remains limited. According to Dr. McCullough, “ This study reveals an exciting new potential that should expand the consideration of ivermectin and mebendazole for inclusion in the treatment of multiple cancer types. We urgently need a full-fledged scientific investigation into this class of medications and their impact on cancer treatment.” How You Can Get Ivermectin + Mebendazole The Wellness Company is the only company in the world to prescribe compounded Ivermectin + Mebendazole, in a high-dose 90-day supply: Ivermectin - Backed by science and honored with a Nobel Prize, Ivermectin delivers precise treatment against parasitic infections, ensuring effective care and well-being for your family with trusted precision. Mebendazole - Trusted by healthcare professionals, Mebendazole targets and eliminates intestinal parasites with precision, ensuring your family's health and well-being with proven efficacy and safety. Head over to The Wellness Company today to order a 90-day supply of the ultimate parasite cleanse – Ivermectin + Mebendazole. Simply fill out the 2-minute intake questionnaire after checkout to complete your prescription request. What people are saying about The Wellness Company’s Ivermectin + Mebendazole: I am grateful to have a medicine as potentially beneficial as ivermectin and mebendazole, but the most important thing for me is the faith I have in Dr. McCullough and The Wellness Company for making a safe product, in our country. I am grateful for them protecting us through the use of proven products and the peace in knowing that I’m taking something that is precisely what it states on the labels . - Jennifer W. My daughter was diagnosed with uterine cancer and lung nodules that turned out to be cancerous. She started taking ivermectin/mebendazole 2 weeks ago. She had a PET scan last month and her lungs were littered with dime and pea sized nodules from the top to the bottom of her lungs. She had a biopsy on the 14th of April and the Physcian had to SEARCH for a nodule big enough to get a sample from, and the ONE that he found was at the bottom of her left lung that he said was only a few centimeters wide…. Thank All of you Doctors on this site for giving us HOPE and HEALING!!! – Helen Order Ivermectin and Mebendazole from The Wellness Company today! ### 相关股票 - [000863.CN](https://longbridge.com/zh-CN/quote/000863.CN.md) - [HCWC.US](https://longbridge.com/zh-CN/quote/HCWC.US.md) - [WNB.AU](https://longbridge.com/zh-CN/quote/WNB.AU.md) - [AYRWF.US](https://longbridge.com/zh-CN/quote/AYRWF.US.md) - [IXJ.US](https://longbridge.com/zh-CN/quote/IXJ.US.md) - [IHF.US](https://longbridge.com/zh-CN/quote/IHF.US.md) - [XHS.US](https://longbridge.com/zh-CN/quote/XHS.US.md) - [XLV.US](https://longbridge.com/zh-CN/quote/XLV.US.md) ## 相关资讯与研究 - [瑞银上调爵士制药评级：核心业务韧性强劲，新药 Ziihera 成增长引擎](https://longbridge.com/zh-CN/news/286920691.md) - [核心医疗累亏超 4 亿：产品单价下行，递表前五次股权转让价剧烈波动](https://longbridge.com/zh-CN/news/286981242.md) - [礼来押注非病毒基因药物，斥资 2.02 亿美元收购 Engage Bio](https://longbridge.com/zh-CN/news/287086583.md) - [默沙东 ADC 药物达 III 期主要终点](https://longbridge.com/zh-CN/news/286929703.md) - [Scholar Rock 将出席杰富瑞全球医疗保健大会，聚焦 SMA 新药 apitegromab 关键审批](https://longbridge.com/zh-CN/news/287069556.md)